PL1784402T3 - Pochodne pirolo[3,2-c]pirydyny oraz sposoby ich wytwarzania - Google Patents

Pochodne pirolo[3,2-c]pirydyny oraz sposoby ich wytwarzania

Info

Publication number
PL1784402T3
PL1784402T3 PL05781131T PL05781131T PL1784402T3 PL 1784402 T3 PL1784402 T3 PL 1784402T3 PL 05781131 T PL05781131 T PL 05781131T PL 05781131 T PL05781131 T PL 05781131T PL 1784402 T3 PL1784402 T3 PL 1784402T3
Authority
PL
Poland
Prior art keywords
pyrrolo
pyridine derivatives
processes
preparation
pharmaceutically acceptable
Prior art date
Application number
PL05781131T
Other languages
English (en)
Inventor
Jae-Gyu Kim
Byung-Nak Ahn
Hyouk-Woo Lee
Suk-Won Yoon
Young-Ae Yoon
Dong-Hoon Kim
Se-Hoon Keum
Young-Ah Shin
Heui-Il Kang
Ryong Choi
Original Assignee
Yuhan Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yuhan Corp filed Critical Yuhan Corp
Publication of PL1784402T3 publication Critical patent/PL1784402T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL05781131T 2004-09-03 2005-09-03 Pochodne pirolo[3,2-c]pirydyny oraz sposoby ich wytwarzania PL1784402T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20040070536 2004-09-03
PCT/KR2005/002924 WO2006025714A1 (en) 2004-09-03 2005-09-03 PYRROLO[3,2-c]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF
EP05781131A EP1784402B1 (en) 2004-09-03 2005-09-03 PYRROLO[3,2-c]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF

Publications (1)

Publication Number Publication Date
PL1784402T3 true PL1784402T3 (pl) 2011-12-30

Family

ID=36000316

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05781131T PL1784402T3 (pl) 2004-09-03 2005-09-03 Pochodne pirolo[3,2-c]pirydyny oraz sposoby ich wytwarzania

Country Status (17)

Country Link
US (2) US8148529B2 (pl)
EP (1) EP1784402B1 (pl)
JP (1) JP5126830B2 (pl)
KR (1) KR100946219B1 (pl)
CN (1) CN101018788B (pl)
AT (1) ATE518858T1 (pl)
AU (1) AU2005280738B2 (pl)
BR (1) BRPI0514843A (pl)
CA (1) CA2578880C (pl)
DK (1) DK1784402T3 (pl)
ES (1) ES2367312T3 (pl)
HK (1) HK1105977A1 (pl)
MX (1) MX2007002214A (pl)
PL (1) PL1784402T3 (pl)
PT (1) PT1784402E (pl)
RU (1) RU2378275C2 (pl)
WO (1) WO2006025714A1 (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008017466A1 (en) * 2006-08-08 2008-02-14 Nycomed Gmbh Pharmaceutically active tetrahydroisoquinoline-substituted benzimidazole derivatives
US8648080B2 (en) 2009-07-09 2014-02-11 Raqualia Pharma Inc. Acid pump antagonist for the treatment of diseases involved in abnormal gastrointestinal motility
GB2517908A (en) * 2013-08-14 2015-03-11 Kalvista Pharmaceuticals Ltd Bicyclic inhibitors
TWI636047B (zh) 2013-08-14 2018-09-21 英商卡爾維斯塔製藥有限公司 雜環衍生物
CN103626767A (zh) * 2013-12-04 2014-03-12 上海药明康德新药开发有限公司 区域选择性的氮杂吲哚及其合成方法
GB201421083D0 (en) 2014-11-27 2015-01-14 Kalvista Pharmaceuticals Ltd Enzyme inhibitors
BR112018006636B1 (pt) 2015-10-09 2023-03-28 Wave Life Sciences Ltd Composição de oligonucleotídeo, composição farmacêutica e uso da composição de oligonucleotídeo
SG11201809922YA (en) 2016-05-31 2018-12-28 Kalvista Pharmaceuticals Ltd Pyrazole derivatives as plasma kallikrein inhibitors
GB201609607D0 (en) 2016-06-01 2016-07-13 Kalvista Pharmaceuticals Ltd Polymorphs of N-(3-Fluoro-4-methoxypyridin-2-yl)methyl)-3-(methoxymethyl)-1-({4-((2-oxopy ridin-1-yl)methyl)phenyl}methyl)pyrazole-4-carboxamide and salts
GB201719881D0 (en) 2017-11-29 2018-01-10 Kalvista Pharmaceuticals Ltd Solid forms of plasma kallikrein inhibitor and salts thereof
LT3716952T (lt) 2017-11-29 2022-04-11 Kalvista Pharmaceuticals Limited Vaisto formos, apimančios plazmos kalikreino inhibitorių
EP4010333A1 (en) 2019-08-09 2022-06-15 Kalvista Pharmaceuticals Limited Plasma kallikrein inhibitors

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3269604D1 (en) * 1981-06-26 1986-04-10 Schering Corp Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
JP3465827B2 (ja) * 1993-02-24 2003-11-10 株式会社日清製粉グループ本社 アザインドール誘導体およびこれを有効成分とする抗潰瘍薬
ES2185693T3 (es) * 1994-01-19 2003-05-01 Sankyo Co Derivado de pirrolopiridacina.
JP2896532B2 (ja) 1994-08-13 1999-05-31 ユーハン コーポレーション 新規なピリミジン誘導体およびその製造方法
EP0849274A1 (en) * 1996-12-20 1998-06-24 Schering Aktiengesellschaft Bissteroidal compounds and their use for the preparation of chiral complexes
SE9700661D0 (sv) 1997-02-25 1997-02-25 Astra Ab New compounds
SE9704404D0 (sv) 1997-11-28 1997-11-28 Astra Ab New compounds
ATE346050T1 (de) * 1998-01-27 2006-12-15 Aventis Pharma Inc Substituierte oxoazaheterocyclyl faktor xa hemmer
CZ292335B6 (cs) 1998-09-23 2003-09-17 Altana Pharma Ag Tetrahydropyridoethery, jejich použití a farmaceutický prostředek
US20040110785A1 (en) * 2001-02-02 2004-06-10 Tao Wang Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
US20040235867A1 (en) * 2001-07-24 2004-11-25 Bilodeau Mark T. Tyrosine kinase inhibitors

Also Published As

Publication number Publication date
ATE518858T1 (de) 2011-08-15
US8513277B2 (en) 2013-08-20
JP2008511618A (ja) 2008-04-17
RU2007112108A (ru) 2008-10-10
RU2378275C2 (ru) 2010-01-10
US20120065224A1 (en) 2012-03-15
KR100946219B1 (ko) 2010-03-08
AU2005280738B2 (en) 2010-11-25
AU2005280738A1 (en) 2006-03-09
US8148529B2 (en) 2012-04-03
US20090005409A1 (en) 2009-01-01
EP1784402A4 (en) 2009-12-23
CA2578880A1 (en) 2006-03-09
BRPI0514843A (pt) 2008-06-24
CA2578880C (en) 2013-01-29
EP1784402A1 (en) 2007-05-16
EP1784402B1 (en) 2011-08-03
DK1784402T3 (da) 2011-11-14
ES2367312T3 (es) 2011-11-02
HK1105977A1 (en) 2008-02-29
MX2007002214A (es) 2007-05-07
KR20060051002A (ko) 2006-05-19
CN101018788A (zh) 2007-08-15
JP5126830B2 (ja) 2013-01-23
CN101018788B (zh) 2010-08-25
PT1784402E (pt) 2011-08-23
WO2006025714A1 (en) 2006-03-09

Similar Documents

Publication Publication Date Title
HK1105979A1 (en) Pyrrolo [3,2-c] pyridine derivatives and processes for the preparation
HK1105977A1 (en) Pyrrolo [3,2-c] pyridine derivatives and processes for the preparation
UA83091C2 (en) Pyrido[2,3-d]pyrimidine-2,4-diamines as pde 2 inhibitors
WO2006011050A3 (en) Pyridine derivatives
WO2006126082A3 (en) Pyridine [3,4-b] pyrazinones as pde-5 inhibitors
WO2003053368A3 (en) Chalcone derivatives and their use to treat diseases
WO2006023515A3 (en) Novel thiazole inhibitors of fructose 1,6-bisphosphatase
WO2006116733A3 (en) Protein kinase inhibitors
WO2005037825A3 (en) Protein kinase inhibitors
UA92637C2 (en) Pyridine[3,4-b]pyrazinones
DE602004007239D1 (de) 4-AMINOTHIENOÄ2,3-dÜ PYRIMIDIN -6-CARBONITRIL-DERIVATIVE ZUR VERWENDUNG ALS PDE7 INHIBITOREN
WO2004063151A3 (en) Novel tyrosine kinase inhibitors
WO2003053359A3 (en) 1,3-bis-(substituted-phenyl)-2-propyn-1-ones and their use to treat disorders
WO2006000371A3 (en) Pyrimidine derivatives as 11beta-hsd1 inhibitors
WO2007053844A3 (en) Compositions and methods for treating inflammatory disorders
WO2004108715A8 (en) 3-aryloxy and 3-heteroaryloxy substituted benzo(b) thiophenes as therapeutic agents with pi3k activity
WO2005021544A3 (en) N3-substituted imidazopyridine-derivatives as c-kit inhibitors
WO2005004808A3 (en) TETRACYCLIC COMPOUNDS AS c-MET INHIBITORS
WO2006016067A3 (fr) Derives de pyrido-pyrimidine, leur preparation, leur application dans le traitement du cancer
AP1564A (en) Piperazinyl sulfonic acid derivatives, their pharmaceutical compositions and methods of use.
WO2004110990A3 (en) Imidazothiazoles and imidazoxazole derivatives as inhibitors of p38
WO2006124865A3 (en) Biaryls derivatives useful as modulators of ion channels
WO2006110173A3 (en) Novel compounds
WO2006072000A3 (en) Xanthurenic acid derivative pharmaceutical compositoins and methods related thereto
HK1105978A1 (en) Pyrrolo [3,2-c]pyridine derivatives and processes for the preparation thereof